Speaker illustration

Professor Stephen Nicholls

Monash University, Melbourne (Australia)

Member of:

European Society of Cardiology

Frontiers in cardiometabolic disease

Event: ESC Asia 2022 with APSC & AFC

Topic: European Society of Cardiology

Session type: Special Session

Thumbnail

Meet the Experts: atherosclerosis regression and plaque modification

Event: ESC Congress 2022

Topic: Lipids

Session type: Meet the Experts

Thumbnail

Cardiovascular risk assessment - Biomarkers & imaging

Event: ESC Congress 2022

Topic: Imaging

Session type: Moderated ePosters

Thumbnail

What you need to know about your patient’s lipid profile

Event: ESC Congress 2022

Topic: Lipids

Session type: Cardiology Toolbox

Thumbnail

Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events (EBAC Accredited)

Event: ESC Congress 2018

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Lipid-lowering therapy beyond LDL Cholesterol

Event: ESC Congress 2018

Topic: Lipids

Session type: Symposium

Thumbnail

Late Breaking Pharmacological Science

Event: ESC Congress 2018

Topic: Pharmacology and Pharmacotherapy

Session type: Late-Breaking Science

Thumbnail

Making an impact: optimal secondary prevention following acute coronary syndromes

Event: ESC Congress 2017

Topic: Adjunctive medical therapy

Session type: Expert Advice

Thumbnail

The clinical trial update in blood cholesterol management 2016

Event: ESC Congress 2016

Topic: Atherosclerosis

Session type: Satellite Symposium

Thumbnail

The state of the science of LDL-C lowering in patients with coronary atherosclerosis

Event: ESC Congress 2016

Topic: Atherosclerosis

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb